Cargando…
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth
Glycogen debranching enzyme (AGL) and Glycogen phosphorylase (PYG) are responsible for glycogen breakdown. We have earlier shown that AGL is a regulator of bladder tumor growth. Here we investigate the role of AGL in non-small cell lung cancers (NSCLC). Short hairpin RNA (shRNA) driven knockdown of...
Autores principales: | Richmond, Craig S., Oldenburg, Darby, Dancik, Garrett, Meier, David R., Weinhaus, Benjamin, Theodorescu, Dan, Guin, Sunny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908281/ https://www.ncbi.nlm.nih.gov/pubmed/29682180 http://dx.doi.org/10.18632/oncotarget.24676 |
Ejemplares similares
-
CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
por: Oldenburg, Darby, et al.
Publicado: (2016) -
Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations
por: Zhai, Liting, et al.
Publicado: (2016) -
Phylogenomic analysis of glycogen branching and debranching enzymatic duo
por: Zmasek, Christian M, et al.
Publicado: (2014) -
Genomic case report of a low grade bladder tumor metastasis to lung
por: Van Every, Marvin J., et al.
Publicado: (2018) -
Robust Prognostic Gene Expression Signatures in Bladder Cancer and Lung Adenocarcinoma Depend on Cell Cycle Related Genes
por: Dancik, Garrett M., et al.
Publicado: (2014)